$30,000 of BAXTER INTERNATIONAL lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Reimbursement, coding and coverage for inpatient and outpatient products. Reimbursement, coding and coverage for inpatient and outpatient products."
You can find more data on corporate lobbying on Quiver Quantitative.
AXTI Insider Trading Activity
AXTI insiders have traded $AXTI stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AXTI stock by insiders over the last 6 months:
- MORRIS S YOUNG (CHAIRMAN AND CEO) purchased 30,000 shares for an estimated $40,929
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXTI Hedge Fund Activity
We have seen 26 institutional investors add shares of AXTI stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SYSTEMATIC FINANCIAL MANAGEMENT LP removed 1,551,380 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,187,445
- OBERWEIS ASSET MANAGEMENT INC/ removed 865,721 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,878,614
- KENNEDY CAPITAL MANAGEMENT LLC removed 830,215 shares (-90.7%) from their portfolio in Q1 2025, for an estimated $1,170,603
- NEEDHAM INVESTMENT MANAGEMENT LLC removed 824,600 shares (-58.1%) from their portfolio in Q1 2025, for an estimated $1,162,686
- D. E. SHAW & CO., INC. removed 451,968 shares (-74.5%) from their portfolio in Q1 2025, for an estimated $637,274
- RENAISSANCE TECHNOLOGIES LLC removed 321,996 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $454,014
- TWO SIGMA INVESTMENTS, LP removed 301,644 shares (-53.4%) from their portfolio in Q1 2025, for an estimated $425,318
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
